Berkshire Asset Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.92M | Sell |
45,234
-1,124
| -2% | -$108K | 0.17% | 72 |
|
|
2025
Q4 | $4.45M | Sell |
46,358
-11,801
| -20% | -$1.15M | 0.2% | 70 |
|
|
2025
Q3 | $5.54M | Sell |
58,159
-1,826
| -3% | -$168K | 0.24% | 67 |
|
|
2025
Q2 | $5.23M | Sell |
59,985
-247
| -0.4% | -$20.9K | 0.24% | 65 |
|
|
2025
Q1 | $5.04M | Sell |
60,232
-3,089
| -5% | -$276K | 0.24% | 64 |
|
|
2024
Q4 | $5.71M | Sell |
63,321
-14,469
| -19% | -$1.25M | 0.27% | 63 |
|
|
2024
Q3 | $6.12M | Hold |
77,790
| – | – | 0.31% | 57 |
|
|
2024
Q2 | $6.12M | Buy |
77,790
+11,033
| +17% | +$904K | 0.31% | 58 |
|
|
2024
Q1 | $5.82M | Sell |
66,757
-738
| -1% | -$63K | 0.31% | 57 |
|
|
2023
Q4 | $5.56M | Sell |
67,495
-3,938
| -6% | -$300K | 0.32% | 57 |
|
|
2023
Q3 | $5.6M | Sell |
71,433
-365
| -0.5% | -$30.6K | 0.35% | 53 |
|
|
2023
Q2 | $6.33M | Buy |
71,798
+414
| +0.6% | +$35.6K | 0.38% | 52 |
|
|
2023
Q1 | $5.75M | Sell |
71,384
-796
| -1% | -$64.9K | 0.36% | 53 |
|
|
2022
Q4 | $5.61M | Buy |
72,180
+10,416
| +17% | +$844K | 0.36% | 53 |
|
|
2022
Q3 | $4.99M | Sell |
61,764
-2,573
| -4% | -$231K | 0.35% | 53 |
|
|
2022
Q2 | $5.77M | Sell |
64,337
-4,127
| -6% | -$418K | 0.38% | 54 |
|
|
2022
Q1 | $7.6M | Sell |
68,464
-1,483
| -2% | -$157K | 0.48% | 48 |
|
|
2021
Q4 | $7.24M | Sell |
69,947
-2,909
| -4% | -$337K | 0.44% | 49 |
|
|
2021
Q3 | $9.13M | Buy |
72,856
+2,070
| +3% | +$268K | 0.61% | 46 |
|
|
2021
Q2 | $8.79M | Sell |
70,786
-8,753
| -11% | -$1.1M | 0.59% | 46 |
|
|
2021
Q1 | $9.4M | Sell |
79,539
-1,955
| -2% | -$229K | 0.7% | 45 |
|
|
2020
Q4 | $9.55M | Buy |
81,494
+4,932
| +6% | +$543K | 0.73% | 44 |
|
|
2020
Q3 | $7.96M | Sell |
76,562
-2,094
| -3% | -$210K | 0.77% | 42 |
|
|
2020
Q2 | $7.21M | Sell |
78,656
-5,206
| -6% | -$499K | 0.66% | 45 |
|
|
2020
Q1 | $7.56M | Buy |
83,862
+4,463
| +6% | +$475K | 0.79% | 43 |
|
|
2019
Q4 | $9.01M | Sell |
79,399
-1,822
| -2% | -$200K | 0.77% | 43 |
|
|
2019
Q3 | $8.82M | Buy |
81,221
+914
| +1% | +$95.4K | 0.76% | 44 |
|
|
2019
Q2 | $7.82M | Buy |
80,307
+78
| +0.1% | +$7.12K | 0.65% | 48 |
|
|
2019
Q1 | $7.31M | Sell |
80,229
-1,000
| -1% | -$89.5K | 0.62% | 47 |
|
|
2018
Q4 | $7.39M | Sell |
81,229
-2,389
| -3% | -$223K | 0.69% | 47 |
|
|
2018
Q3 | $8.23M | Buy |
83,618
+597
| +0.7% | +$55.2K | 0.7% | 47 |
|
|
2018
Q2 | $7.11M | Sell |
83,021
-668
| -0.8% | -$55.8K | 0.67% | 48 |
|
|
2018
Q1 | $6.71M | Sell |
83,689
-3,359
| -4% | -$277K | 0.65% | 47 |
|
|
2017
Q4 | $7.03M | Buy |
87,048
+2,310
| +3% | +$185K | 0.68% | 47 |
|
|
2017
Q3 | $6.59M | Sell |
84,738
-1,942
| -2% | -$161K | 0.74% | 48 |
|
|
2017
Q2 | $7.69M | Sell |
86,680
-504
| -0.6% | -$42.5K | 0.88% | 44 |
|
|
2017
Q1 | $7.02M | Buy |
87,184
+7,764
| +10% | +$606K | 0.83% | 44 |
|
|
2016
Q4 | $5.66M | Buy |
79,420
+1,704
| +2% | +$134K | 0.73% | 48 |
|
|
2016
Q3 | $6.71M | Sell |
77,716
-783
| -1% | -$68.2K | 0.96% | 41 |
|
|
2016
Q2 | $6.81M | Buy |
78,499
+4,429
| +6% | +$358K | 1.04% | 39 |
|
|
2016
Q1 | $5.55M | Sell |
74,070
-216
| -0.3% | -$16.3K | 0.86% | 46 |
|
|
2015
Q4 | $5.71M | Sell |
74,286
-678
| -0.9% | -$51K | 0.95% | 38 |
|
|
2015
Q3 | $5.02M | Sell |
74,964
-2,833
| -4% | -$209K | 0.9% | 44 |
|
|
2015
Q2 | $5.76M | Sell |
77,797
-28
| -0% | -$2.14K | 0.97% | 39 |
|
|
2015
Q1 | $6.07M | Buy |
77,825
+73,685
| +1,780% | +$5.58M | 1.02% | 38 |
|
|
2014
Q4 | $299K | Sell |
4,140
-1,075
| -21% | -$74.7K | 0.05% | 138 |
|
|
2014
Q3 | $323K | Hold |
5,215
| – | – | 0.06% | 133 |
|
|
2014
Q2 | $333K | Sell |
5,215
-180
| -3% | -$10.9K | 0.06% | 129 |
|
|
2014
Q1 | $332K | Sell |
5,395
-100
| -2% | -$5.83K | 0.06% | 124 |
|
|
2013
Q4 | $315K | Buy |
+5,495
| New | +$312K | 0.06% | 136 |
|
Other funds holding MDT
VCM
VPM
Berkshire Asset Management's MDT Position: Q1 2026 in Review
Berkshire Asset Management reduced its Medtronic (MDT) stake by 2.4% in Q1 2026, selling an estimated $108K and leaving 45,234 shares worth $3.92M. The position accounts for 0.17% of the portfolio, ranked #72.
Berkshire Asset Management first reported a position in MDT in Q4 2013 and has held it in 50 quarters since. The position peaked at $9.55M in Q4 2020. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Berkshire Asset Management held 45,234 shares of Medtronic worth $3.92M as of Q1 2026.
- Berkshire Asset Management sold 1,124 Medtronic shares in Q1 2026, an estimated $108K.
- Medtronic made up 0.17% of Berkshire Asset Management's portfolio in Q1 2026, its #72 holding.
- Berkshire Asset Management first reported a position in Medtronic in Q4 2013 and has held it in 50 quarters since.
- Berkshire Asset Management's Medtronic position peaked at $9.55M in Q4 2020.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Berkshire Asset Management's 13F filing for Q1 2026, filed 11 May 2026.